PMID- 18003729 OWN - NLM STAT- MEDLINE DCOM- 20080124 LR - 20211020 IS - 1098-5514 (Electronic) IS - 0022-538X (Print) IS - 0022-538X (Linking) VI - 82 IP - 2 DP - 2008 Jan TI - The spike glycoprotein of murine coronavirus MHV-JHM mediates receptor-independent infection and spread in the central nervous systems of Ceacam1a-/- Mice. PG - 755-63 AB - The MHV-JHM strain of the murine coronavirus mouse hepatitis virus is much more neurovirulent than the MHV-A59 strain, although both strains use murine CEACAM1a (mCEACAM1a) as the receptor to infect murine cells. We previously showed that Ceacam1a(-/-) mice are completely resistant to MHV-A59 infection (E. Hemmila et al., J. Virol. 78:10156-10165, 2004). In vitro, MHV-JHM, but not MHV-A59, can spread from infected murine cells to cells that lack mCEACAM1a, a phenomenon called receptor-independent spread. To determine whether MHV-JHM could infect and spread in the brain independent of mCEACAM1a, we inoculated Ceacam1a(-/-) mice. Although Ceacam1a(-/-) mice were completely resistant to i.c. inoculation with 10(6) PFU of recombinant wild-type MHV-A59 (RA59) virus, these mice were killed by recombinant MHV-JHM (RJHM) and a chimeric virus containing the spike of MHV-JHM in the MHV-A59 genome (SJHM/RA59). Immunohistochemistry showed that RJHM and SJHM/RA59 infected all neural cell types and induced severe microgliosis in both Ceacam1a(-/-) and wild-type mice. For RJHM, the 50% lethal dose (LD(50)) is <10(1.3) in wild-type mice and 10(3.1) in Ceacam1a(-/-) mice. For SJHM/RA59, the LD(50) is <10(1.3) in wild-type mice and 10(3.6) in Ceacam1a(-/-) mice. This study shows that infection and spread of MHV-JHM in the brain are dependent upon the viral spike glycoprotein. RJHM can initiate infection in the brains of Ceacam1a(-/-) mice, but expression of mCEACAM1a increases susceptibility to infection. The spread of infection in the brain is mCEACAM1a independent. Thus, the ability of the MHV-JHM spike to mediate mCEACAM1a-independent spread in the brain is likely an important factor in the severe neurovirulence of MHV-JHM in wild-type mice. FAU - Miura, Tanya A AU - Miura TA AD - Department of Microbiology MS 8333, University of Colorado Health Sciences Center, 12800 E. 19th Ave., P.O. Box 6511, Aurora, CO 80045, USA. FAU - Travanty, Emily A AU - Travanty EA FAU - Oko, Lauren AU - Oko L FAU - Bielefeldt-Ohmann, Helle AU - Bielefeldt-Ohmann H FAU - Weiss, Susan R AU - Weiss SR FAU - Beauchemin, Nicole AU - Beauchemin N FAU - Holmes, Kathryn V AU - Holmes KV LA - eng GR - N01AI60021/AI/NIAID NIH HHS/United States GR - R01 AI025231/AI/NIAID NIH HHS/United States GR - AI60021/AI/NIAID NIH HHS/United States GR - AI25231/AI/NIAID NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20071114 PL - United States TA - J Virol JT - Journal of virology JID - 0113724 RN - 0 (Carcinoembryonic Antigen) RN - 0 (Ceacam1 protein, mouse) RN - 0 (Membrane Glycoproteins) RN - 0 (Spike Glycoprotein, Coronavirus) RN - 0 (Viral Envelope Proteins) RN - 0 (Virulence Factors) SB - IM MH - Animals MH - Brain/pathology/virology MH - Carcinoembryonic Antigen/*genetics MH - Central Nervous System/*virology MH - Coronavirus Infections/*virology MH - Gene Deletion MH - Lethal Dose 50 MH - Membrane Glycoproteins/genetics/*physiology MH - Mice MH - Mice, Inbred C57BL MH - Mice, Knockout MH - Murine hepatitis virus/*growth & development/physiology MH - Spike Glycoprotein, Coronavirus MH - Survival Analysis MH - Viral Envelope Proteins/genetics/*physiology MH - Virulence Factors/genetics/physiology MH - *Virus Internalization PMC - PMC2224565 EDAT- 2007/11/16 09:00 MHDA- 2008/01/25 09:00 PMCR- 2008/05/01 CRDT- 2007/11/16 09:00 PHST- 2007/11/16 09:00 [pubmed] PHST- 2008/01/25 09:00 [medline] PHST- 2007/11/16 09:00 [entrez] PHST- 2008/05/01 00:00 [pmc-release] AID - JVI.01851-07 [pii] AID - 1851-07 [pii] AID - 10.1128/JVI.01851-07 [doi] PST - ppublish SO - J Virol. 2008 Jan;82(2):755-63. doi: 10.1128/JVI.01851-07. Epub 2007 Nov 14.